Contrast-Enhanced Endoscopic Ultrasound for Evaluation of Pancreas Lesions

What is the Purpose of this Study?

The goal of this study is to determine whether quantitative contrast-enhanced endoscopic ultrasound improves the evaluation of pancreas tumors and precursor lesions, including cysts, compared to conventional endoscopic ultrasound.


Eligibility

  • * Patients undergoing endoscopic ultrasound for pancreatic indications
  • * Patients must have unexplained pancreatitis, pancreas mass(es), or pancreatic cystic lesions or worrisome clinical, imaging or laboratory findings
Show more

Where can I participate?

CS Cancer at Cedars-Sinai Medical Center

More about this Clinical Trial

What is the full name of this clinical trial?

IIT2019-22-GADDAM-LUMASON: The Role of Contrast Enhanced Endoscopic Ultrasound for Evaluation of Pancreas Lesions

Study Details
Disease Type/Condition

Pancreas

Principal Investigator

Gaddam, Srinivas

Co-Investigators

Ashley Wachsman, Kenneth Park, Quin Liu, Simon Lo, Stephen Pandol

Age Group

Adult

Phase

N/A (Cancer Control) (Cancer Prevention)

IRB Number

STUDY00000259

ClinicalTrials.gov ID

NCT04324294

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Pancreas

Principal Investigator

Gaddam, Srinivas

Age Group

Adult

Phase

N/A (Cancer Control) (Cancer Prevention)

IRB Number

IIT2019-22-GADDAM-LUMASON

ClinicalTrials.gov ID

NCT04324294

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org